Rangeley Capital, LLC
- SEC CIK
- 0001517796
- Latest filing
- Aug 14, 2026
IKT holding history
Inhibikase Therapeutics, Inc. in every 13F filed by Rangeley Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IKT overviewAll 13F holders of IKTFull Q2 2026 holdings
- Shares (Q2 2026)
- 220,000
- Value
- $446.6K
- % of portfolio
- 0.4%
- Quarters held
- 2
- Since Q1 2026